-- The London Proteomics Discussion Group --
Proteomics seminar series for the South East
We are a free, local proteomics seminar series in the South East,
with a focus towards networking, discussion and supporting early career researchers.
The LPDG...
was founded to bring together the large community of proteomics scientists all working in and around London. We aim to provide a space for discussion, with a focus on methods and early career researchers (two fundamental building blocks of good research!), on all topics related to proteomics. The meetings comprise of research talks framed by a proteomics methods challenge, lunch, refreshments and pizza - they are free to attend thanks to sponsorship.
Meeting Dates:
Happy to be here on Bluesky. We'll be doing a little series of "meet the committee members" over the next few weeks, having just held our elections for new members. Look out for the old and new faces coming soon 😊
— London Proteomics Discussion Group (@lpdg.bsky.social) December 8, 2024 at 7:00 PM
These seminars would not be possible without our amazing sponsors.
If you are interested in sponsoring an LPDG seminar,
please get in touch at sponsor@londonproteomics.co.uk
for 22nd May 2025 Time 12:00
Would you like to present at an LPDG meeting? Email: speaker@londonproteomics.co.uk
Research presentations from:
Dr Johanna Jackson is an Advanced Research Fellow at Imperial College London and an Alzheimer’s Society Dementia Leader. After her PhD at Imperial and post docs at Lund University and Imperial, she joined Eli Lilly where she became a team leader and co-chaired their Neuroplasticity Drug Discovery platform. She has led the UK DRI Multi-‘omics Atlas Project; an open resource mapping the cellular pathology of AD. Her lab investigates the vulnerability of synaptic components, repurposed therapeutics and biomarkers in order to therapeutically target the synapse in AD
TBC
I am Principal Scientist in R&D Dpt in Lonza Biologics and focus on use of proteomics and multi-omics for applications in bioprocessing including MS-based analysis of host cell proteins, identification of predictive markers and targets for further improvements of expression system.
Dr Irbaz I. Badshah is a postdoctoral researcher specialising inbioinformatics and cell signalling. His recent work involves developing statistical methods to systematically identify biochemical networks in cancer cells, aiming to understand cancer dependencies and potential therapeutic targets. Currently, he is engineering efficient tools for the quantification and analysis of proteomic mass spectrometry data, utilising advanced computational approaches, including machine learning.